GA HB1170

Qualified government buildings and courthouses that already contain automated external defibrillators must maintain at least three unit doses of opioid antagonists (e.g., naloxone) and make them accessible during business hours and government events.

The Department of Public Health, in consultation with the Department of Behavioral Health and Developmental Disabilities, must develop educational resources, guidelines, and a model training policy for opioid antagonist administration, published on its website.

Trained government employees, officers, agents, contractors, and other individuals who administer opioid antagonists in good faith during a suspected overdose are granted immunity from civil liability and professional discipline, excluding cases of willful misconduct, gross negligence, or recklessness.

Strengthens existing restrictions on gender-transition treatments for minors by expanding the prohibition beyond gender dysphoria treatment to cover any hormone therapy, puberty blocking medication, or sex reassignment surgery performed for the purpose of altering a minor's sex or affirming a gender identity inconsistent with the minor's biological sex.

Repeals the prior exception that allowed continued hormone therapy for minors who were already receiving treatment before July 1, 2023, and removes the exception for medically necessary treatments for conditions other than gender dysphoria, while preserving exceptions for disorders of sex development and partial androgen insensitivity syndrome. Parents or guardians may pursue civil or criminal remedies for violations.